News
Stock Market News for Oct 20, 2025
Wall Street closed higher on Friday, driven by consumer and financial stocks. Banking stocks steadied after the recent turmoil, and investors welcomed remarks by Donald Trump softening the stance on
Abbott Q3 Earnings Review: Tariff, Diagnostics Cap Near-Term Gains
Shares of Abbott ABT have edged up 0.7% since the company’s third-quarter 2025 earnings release on Oct. 15, 2025. The company reported a strong year-over-year increase in adjusted earnings and
Is Western Digital (WDC) a Buy as Wall Street Analysts Look Optimistic?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
Wall Street Analysts See Deere (DE) as a Buy: Should You Invest?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
Wall Street Analysts Think Micron (MU) Is a Good Investment: Is It?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
Wall Street Analysts Think GigaCloud Technology Inc. (GCT) Is a Good Investment: Is It?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts
Is It Worth Investing in Citigroup (C) Based on Wall Street's Bullish Views?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts
Is Nice (NICE) a Buy as Wall Street Analysts Look Optimistic?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
Is Commvault (CVLT) a Buy as Wall Street Analysts Look Optimistic?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
Is It Worth Investing in Cadence (CDNS) Based on Wall Street's Bullish Views?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
Carnival (CCL) Is Considered a Good Investment by Brokers: Is That True?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
Compared to Estimates, HBT Financial (HBT) Q3 Earnings: A Look at Key Metrics
For the quarter ended September 2025, HBT Financial (HBT) reported revenue of $59.84 million, up 6% over the same period last year. EPS came in at $0.65, compared to $0.61 in the year-ago quarter.
Wall Street Bulls Look Optimistic About MercadoLibre (MELI): Should You Buy?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts
Will Positive Regulatory Updates Further Boost INCY Stock?
Incyte INCY has put up a stellar performance year to date on the back of better-than-expected quarterly results, and positive pipeline and regulatory updates.
INCY’s Lead Drug Jakafi Maintains
Estee Lauder Targets 25% of Sales From Innovation in Fiscal 2026
Estee Lauder Companies (EL) is setting a clear benchmark for creative renewal in fiscal 2026, aiming for more than 25% of total sales to come from innovation. The company described this as a key
Will Cadence's M&A Strategy Reinforce Its Position in the EDA Space?
Cadence Design Systems, Inc. CDNS, a leader in the electronic design automation (“EDA”) space, continues to enhance its business through strategic acquisitions.
Inorganic expansion provides valuable
Alliant Energy Benefits From Investments & Clean Energy Focus
Alliant Energy Corporation’s LNT long-term investments should further strengthen its infrastructure, while returns from regulated assets are expected to provide earnings visibility. The company’s
American Water's Unit Receives Funding to Upgrade Water Assets
American Water Works Company (AWK) announced that its unit, Pennsylvania American Water, received grants and low-interest loans from the Pennsylvania Infrastructure Investment Authority (“PENNVEST”)
Can Chevron's Vaca Muerta Strategy Deliver Long-Term Wins?
Chevron Corporation (CVX) continues to expand its presence in Argentina’s Vaca Muerta shale — one of the world’s largest unconventional oil and gas formations. Having entered the play more than a
Can NTLA's In Vivo Pipeline Aid Long-Term Growth Amid Competition?
Intellia Therapeutics NTLA has made meaningful progress with the development of its in vivo programs. The company is currently advancing two late-stage in vivo candidates — lonvo-z (or, NTLA-2002)
Affirm & Fanatics Team Up to Offer Flexible Payments for Sports Fans
Affirm Holdings, Inc. AFRM has collaborated with Fanatics, a digital sports platform, to offer millions of sports fans more transparent and flexible payment options. This partnership enables
DELL Gains Traction in Cloud Infrastructure: Can it Drive ISG Revenue?
Dell Technologies DELL is expanding its cloud services through its infrastructure solutions and rich partner base that provides essential hardware and services that support cloud environments
SAP Gears Up to Report Q3 Earnings: Is a Beat in the Offing?
SAP SE (SAP) is scheduled to post results for the third quarter of 2025 on Oct. 22, after market close.
The Zacks Consensus Estimate for third-quarter earnings is $1.69 per share, indicating a 25.2%
Stereotaxis Rolls Out Synchrony System in EU and Files for FDA Approval
Stereotaxis STXS announced last week the European launch and U.S. FDA 510(k) submission of its Synchrony system, a next-generation platform designed to modernize interventional cath labs. The system


